Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 203

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells

Open access
Miyamoto, Hiroshi, Yeh, Shuyuan, Wilding, George, Chang, Chawnshang·1998·Proceedings of the National Academy of Sciences

Abstract

Although hormone therapy with antiandrogens has been widely used for the treatment of prostate cancer, some antiandrogens may act as androgen receptor (AR) agonists that may result in antiandrogen withdrawal syndrome. The molecular mechanism of this agonist response, however, remains unclear. Using mammalian two-hybrid assay, we report that antiandrogens, hydroxyflutamide, bicalutamide (casodex), cyproterone acetate, and RU58841, and other compounds such as genistein and RU486, can promote the interaction between AR and its coactivator, ARA70, in a dose-dependent manner. The chloramphenicol acetyltransferase assay further demonstrates that these antiandrogens and related compounds significantly enhance the AR transcriptional activity by cotransfection of AR and ARA70 in a 1:3 ratio into human prostate cancer DU145 cells. Our results suggest that the agonist activity of antiandrogens might occur with the proper interaction of AR and ARA70 in DU145 cells. These findings may provide a good model to develop better antiandrogens without agonist activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.95.13.7379

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 39

  1. 10.1126/science.3353726 · DOI · Paper page
  2. 10.1126/science.3283939 · DOI · Paper page
  3. 10.3322/canjclin.48.1.6 · DOI · Paper page
  4. C Huggins, C V Hodges Cancer Res 1, 293–297 (1941).
  5. 10.1002/pros.2990140204 · DOI · Paper page
  6. 10.1016/S0006-291X(05)80067-1 · DOI · Paper page
  7. 10.1074/jbc.270.34.19998 · DOI · Paper page
  8. 10.1074/jbc.270.46.27569 · DOI
  9. 10.1016/S0140-6736(05)61756-4 · DOI
  10. 10.1016/S0022-5347(17)36163-3 · DOI · Paper page
  11. 10.1200/JCO.1993.11.8.1566 · DOI · Paper page
  12. 10.1016/S0094-0143(05)70389-X · DOI
  13. 10.1007/BF00941991 · DOI
  14. 10.1016/S0090-4295(96)00558-4 · doi:10.1016/s0090-4295(96)00558-4
  15. 10.1002/1097-0142(19930201)71:3 <1046::AID-CNCR2820711424>3.0.CO;2-M · doi:10.1002/1097-0142(19930201)71:3
  16. F Neumann, G H Jacobi J Clin Oncol 1, 41–65 (1982).
  17. 10.1111/j.1365-2265.1994.tb02585.x · DOI
  18. 10.1159/000463971 · doi:10.1159/000463971
  19. H R Naik, J E Lehr, K J Pienta Anticancer Res 14, 2617–2620 (1994).
  20. 10.1002/pros.2990220408 · DOI · Paper page
  21. 10.1016/0022-4731(87)90159-2 · doi:10.1016/0022-4731(87)90159-2
  22. 10.1093/nar/19.6.1227 · DOI
  23. 10.1016/0960-0760(94)90250-X · doi:10.1016/0960-0760(94)90250-x
  24. 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S · DOI
  25. 10.1016/S0022-5347(17)37389-5 · DOI
  26. J P Gaddiopati, D G McLeod, H B Heidenberg, I A Sesterhenn, M J Finger, J W Moul, S Srivastava Cancer Res 54, 2861–2864 (1994).
  27. 10.1056/NEJM199505253322101 · DOI · Paper page
  28. 10.1073/pnas.93.11.5517 · DOI · Paper page
  29. A Mizokami, S-Y Yeh, C Chang Mol Endocrinol 8, 77–88 (1994).
  30. 10.1016/S0021-9258(18)41805-4 · DOI · Paper page
  31. 10.1016/0303-7207(94)90112-0 · DOI
  32. C Wang Ph.D. thesis (Univ. of Wisconsin-Madison, Madison, WI, 1997).
  33. A Mizokami, M Masai, J Shimazaki, A Sugita Nippon Hinyokika Gakkai Zasshi 83, 1801–1807 (1992).
  34. 10.1038/375377a0 · DOI · Paper page
  35. 10.1038/378681a0 · DOI · Paper page
  36. 10.1038/378690a0 · DOI · Paper page
  37. 10.1038/nsb0196-87 · DOI · Paper page
  38. J A Katzenellenbogen, B W O’Malley, B S Katzenellenbogen Mol Endocrinol 10, 119–131 (1996).
  39. M M Montano, V Muller, A Trobaugh, B S Katzenellenbogen Mol Endocrinol 9, 814–824 (1995).

Cited by

See all 203

Metadata

Authors
Miyamoto, H., Yeh, S., Wilding, G., & Chang, C.
Venue
Proceedings of the National Academy of Sciences
Published
1998-06-23
Volume
95
Issue
13
Pages
7379-7384
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2129750923
Cited by
203
References
1
FWCI
18.85
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. https://app.cochat.ai/papers/10.1073/pnas.95.13.7379
The paper
Miyamoto, H., Yeh, S., Wilding, G., & Chang, C. (1998). Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.95.13.7379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.